Aspirin, Caffeine, and Dihydrocodeine Bitartrate (Caraco Pharmaceutical Laboratories, Ltd)
Welcome to the PulseAid listing for the Aspirin, Caffeine, and Dihydrocodeine Bitartrate drug offered from Caraco Pharmaceutical Laboratories, Ltd. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Caraco Pharmaceutical Laboratories, Ltd |
| NON-PROPRIETARY NAME: | Aspirin, Caffeine, and Dihydrocodeine Bitartrate |
| SUBSTANCE NAME: | ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2012-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Aspirin, Caffeine, and Dihydrocodeine Bitartrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aspirin, Caffeine, and Dihydrocodeine Bitartrate from Caraco Pharmaceutical Laboratories, Ltd |
| LABELER NAME: | Caraco Pharmaceutical Laboratories, Ltd |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 356.4; 30; 16(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2012-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57664-419_6f20cd49-8c5a-4349-9611-105bed7537a9 |
| PRODUCT NDC: | 57664-419 |
| APPLICATION NUMBER: | NDA011483 |
Other ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE Pharmaceutical Manufacturers / Labelers:
